Ambu A/S (OTCMKTS:AMBBY) Sets New 52-Week Low – Should You Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $10.00 and last traded at $10.00, with a volume of 118 shares traded. The stock had previously closed at $10.3162.

Ambu A/S Stock Performance

The stock’s 50 day moving average price is $11.88 and its 200-day moving average price is $13.49. The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $2.35 billion, a PE ratio of 32.26 and a beta of 1.25.

Ambu A/S (OTCMKTS:AMBBY) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter. The firm had revenue of $242.85 million during the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.